市場調査レポート
商品コード
1464679

脂肪由来幹細胞の世界市場:タイプ別、製品タイプ別、疾患別、技術別、国別、地域別 - 産業分析、市場規模、市場シェア、予測(2024~2032年)

Adipose Derived Stem Cell Market, By Type, By Product Type, By Disease, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 279 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
脂肪由来幹細胞の世界市場:タイプ別、製品タイプ別、疾患別、技術別、国別、地域別 - 産業分析、市場規模、市場シェア、予測(2024~2032年)
出版日: 2024年04月17日
発行: AnalystView Market Insights
ページ情報: 英文 279 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脂肪由来幹細胞の市場規模は、2023年に21億4,450万米ドルに達し、2024~2032年にかけてCAGR 14.5%で拡大すると予測されています。

脂肪由来幹細胞市場 - 市場力学

低侵襲の美容整形に対する需要の高まりが市場成長を促進すると予測

脂肪吸引は、ADSC分離のために脂肪組織を採取するために一般的に使用されている手技であり、ADSCに基づく治療のための脂肪組織の利用可能性に寄与しています。米国形成外科学会(ASPS)は、2018年に米国で約1,800万人が外科的および低侵襲的な美容整形手術を受けたと報告しており、増加傾向を示しています。このような市場の成長は、ADSCに基づく製品や治療法を商品化する企業にも機会をもたらしています。ただし、安全性への懸念が市場拡大に制約をもたらす可能性があることには注意が必要です。

脂肪由来幹細胞市場 - 主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024~2032年)にCAGR約14.5%で毎年成長すると予測されています。

タイプ別では、同種幹細胞が2023年に最大の市場シェアを示すと予測されています。

地域別では、北米が2023年の売上高をリードしています。

脂肪由来幹細胞市場 - セグメンテーション分析:

世界の脂肪由来幹細胞市場は、タイプ、製品タイプ、疾患、技術、地域に基づいてセグメント化されます。

市場はタイプによって2つのグループに分類される:すなわち、自家幹細胞と同種幹細胞です。同種幹細胞が市場の大半を占めています。脂肪由来幹細胞と同種幹細胞の組み合わせは、再生医療における重要な研究分野であり、進歩です。これらの幹細胞の供給源は明確な利点を提供し、様々な疾患や病状の治療の可能性について現在研究が進められています。

市場は製品タイプによって4つのグループに区分される:細胞株、培養液、培地、血清、試薬です。脂肪由来幹細胞市場には、細胞株、培養液、培地、血清、試薬などの幅広い製品が含まれ、これらはいずれも再生医療分野における研究開発および商業化の推進に不可欠なものです。

市場は疾患別に8つのカテゴリーに分類されている:がん、肥満、創傷・怪我、筋骨格系疾患、心臓血管系疾患、中枢神経系疾患、代謝性疾患、消化器系疾患、その他の疾患です。脂肪由来幹細胞は汎用性が高く、再生能力を有することから、幅広い医療分野における革新的な治療法の有望な候補として位置づけられています。

同市場は、エンドユーザー別に、細胞バンク・組織バンク、研究所・学術機関、病院・外傷センター、その他に分類されます。再生医療分野の進歩を促進し、ADSCに基づく治療法の臨床応用を促進するためには、これらの利害関係者の連携と学際的な取り組みが不可欠です。

脂肪由来幹細胞市場 - 地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカに広く広がっています。これらの地域は、事業活動を行っている国に基づいてさらに分類されます。市場は主に北米が支配的であるが、これは主に様々な組織による研究開発イニシアチブの数が増加しているためです。特に、米国国立衛生研究所(NIH)のような北米の政府機関は、幹細胞研究に多額の資金を提供することで重要な役割を果たしています。この財政支援は、研究開発努力を大きく加速させ、技術革新を促進し、ADSCの生物学的理解と治療応用の進歩に貢献しています。2019年、米国は研究開発(R&D)の目覚ましい業績を目の当たりにし、6,670億米ドルに達したが、全米科学財団の報告によると、2020年にはさらに増加して7,080億米ドルに達すると推定されています。欧州は、主に再生医療に対する消費者の意識の高まりによって、市場成長において第2位の地域を占めています。

脂肪由来幹細胞市場 - 競合情勢:

脂肪由来幹細胞(ADSC)市場の競合情勢は、さまざまな医療分野におけるADSCの治療効果に対する意識の高まりによって形成されています。各企業は、研究および臨床の両分野でADSCを分離、拡大、応用するための独自の製品や技術を開発することで、他社との差別化を図っています。また、新しい地域に進出したり、販売業者と提携したり、再生美容や獣医学などの新興分野に注力したりすることで、ADSC市場でのリーチを広げようとしています。市場拡大の戦略としては、規制当局の承認取得、市場参入イニシアティブの開始、ヘルスケア産業の有力者との戦略的パートナーシップの形成などが考えられます。

目次

第1章 脂肪由来幹細胞の市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 脂肪由来幹細胞の主要市場動向

  • 脂肪由来幹細胞市場の促進要因
  • 脂肪由来幹細胞市場の抑制要因
  • 脂肪由来幹細胞市場機会
  • 脂肪由来幹細胞市場の今後の動向

第4章 脂肪由来幹細胞の産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 脂肪由来幹細胞市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 脂肪由来幹細胞の市場情勢

  • 脂肪由来幹細胞市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存プレイヤーの分析
    • 新興プレーヤーの分析

第7章 脂肪由来幹細胞市場 - タイプ別

  • 概要
    • セグメントシェア分析、タイプ別
    • 自家幹細胞
    • 同種幹細胞

第8章 脂肪由来幹細胞市場 - 製品タイプ別

  • 概要
    • セグメントシェア分析、製品タイプ別
    • 細胞株
    • 培養液
    • 培地
    • 血清
    • 試薬

第9章 脂肪由来幹細胞市場 - 疾患別

  • 概要
    • セグメントシェア分析、疾患別
    • がん
    • 肥満
    • 傷・負傷
    • 筋骨格系疾患
    • 心血管疾患
    • 中枢神経系疾患
    • 代謝性疾患
    • 胃腸疾患
    • その他

第10章 脂肪由来幹細胞市場 - エンドユーザー別

  • 概要
    • セグメントシェア分析、エンドユーザー別
    • 細胞バンク・組織バンク
    • 研究室・学術機関
    • 病院・外傷センター
    • その他

第11章 脂肪由来幹細胞市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析 - 脂肪由来幹細胞産業

  • 競合ダッシュボード
  • 企業プロファイル
    • AlloCure
    • Antria
    • Celgene Corporation
    • Cellleris
    • Corestem
    • Cytori Therapeutics
    • Intrexon
    • Mesoblast
    • Pluristem Therapeutics
    • Tissue Genesis
    • BioRestorative Therapies
    • Celltex Therapeutics Corporation
    • iXCells Biotechnologies
    • Cyagen
    • Lonza
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Adipose Derived Stem CellMarket: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Adipose Derived Stem CellMarket, by Type 2019-2032 (USD Million)
  • TABLE Adipose Derived Stem CellMarket: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Adipose Derived Stem CellMarket, by Product Type 2019-2032 (USD Million)
  • TABLE Adipose Derived Stem CellMarket: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Adipose Derived Stem CellMarket, by Disease 2019-2032 (USD Million)
  • TABLE Adipose Derived Stem CellMarket: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Adipose Derived Stem CellMarket, by End-User 2019-2032 (USD Million)
  • TABLE Adipose Derived Stem CellMarket: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Adipose Derived Stem CellMarket, by Region 2019-2032 (USD Million)
  • TABLE North America Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
  • TABLE North America Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
  • TABLE North America Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
  • TABLE North America Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
  • TABLE Europe Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
  • TABLE Europe Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Adipose Derived Stem CellMarket, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Adipose Derived Stem CellMarket, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Adipose Derived Stem CellMarket, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Adipose Derived Stem CellMarket, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Adipose Derived Stem CellMarket, by End-User, 2019-2032 (USD Million)
目次
Product Code: ANV2485

REPORT HIGHLIGHT

Adipose Derived Stem Cell Market size was valued at USD 2,144.5 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

Adipose-derived stem cells (ADSCs) possess the ability to sustain self-renewal and exhibit an enhanced potential for multiple types of differentiation. This is achieved through the secretion of diverse paracrine factors and extracellular vesicles, enabling them to effectively restore impaired organs and tissues. As a result, there has been a growing focus on utilizing ADSCs in the fields of tissue engineering and organ regeneration. Obtaining ADSCs in substantial quantities is relatively straightforward, as they can be acquired through minimally invasive techniques like liposuction. This accessibility renders them an appealing source for applications in regenerative medicine and tissue engineering. Extensive research has been conducted to explore their therapeutic potential in addressing various medical conditions, including tissue repair, wound healing, and the regeneration of damaged or diseased tissues.

Adipose Derived Stem Cell Market- Market Dynamics

Rising demand for minimally invasive cosmetic procedures is anticipated to fuel market growth

Liposuction, which is a commonly used procedure for harvesting adipose tissue for ADSC isolation, is contributing to the availability of adipose tissue for ADSC-based therapies. The American Society of Plastic Surgeons (ASPS) reported that nearly 18 million individuals underwent surgical and minimally invasive cosmetic procedures in the United States in 2018, indicating a rising trend. This growth in the market is also creating opportunities for companies to commercialize ADSC-based products and therapies. However, it is important to note that safety concerns may pose restrictions on the market's expansion.

Adipose Derived Stem Cell Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on Type segmentation, Allogeneic Stem Cells were predicted to show maximum market share in the year 2023

Based on region, North America was the leading revenue generator in 2023

Adipose Derived Stem Cell Market- Segmentation Analysis:

The Global Adipose Derived Stem Cell Market is segmented based on Type, Product Type, Disease, Technology and Region.

The market is categorized into two groups according to Type: Autologous Stem Cells and Allogeneic Stem Cells. Allogeneic Stem Cells hold the majority share in the market. The combination of adipose-derived stem cells and allogeneic stem cells is a significant field of study and advancement in regenerative medicine. These sources of stem cells provide distinct benefits and are currently under investigation for their potential in treating various diseases and medical conditions.

The market is segmented into four groups according to Product Type: Cell line, Culture media, Media, Sera, and Reagents. The market for adipose-derived stem cells includes a wide range of products, such as cell lines, culture media, sera, and reagents, all of which are essential for driving progress in research, development, and commercialization within the regenerative medicine sector.

The market is segmented into eight categories according to Disease: Cancer, Obesity, Wounds and Injuries, Musculoskeletal Diseases, Cardiovascular Diseases, Central Nervous System Diseases, Metabolic Diseases, Gastro-intestinal Diseases, and Other conditions. Adipose-derived stem cells are highly versatile and possess regenerative capabilities, positioning them as promising candidates for innovative therapies in a wide range of medical fields.

The market is categorized into three groups based on End-User: Cell banks & tissue banks, Research laboratories and Academic institutes, Hospitals and Trauma centers and Others. It is imperative for collaboration and interdisciplinary efforts among these stakeholders to drive advancements in the field of regenerative medicine and facilitate the translation of ADSC-based therapies into clinical practice.

Adipose Derived Stem Cell Market- Geographical Insights

Geographically, this market is extensively spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved in business activities. The market is predominantly dominated by North America, primarily due to the growing number of research and development initiatives undertaken by various organizations. Notably, government agencies in North America, such as the National Institutes of Health (NIH) in the U.S., play a significant role by providing substantial funding for stem cell research. This financial support greatly accelerates research and development efforts, fosters innovation, and contributes to advancements in understanding ADSC biology and therapeutic applications. In 2019, the United States witnessed a remarkable research and experimental development (R&D) performance, reaching USD 667 billion, and it is estimated to have further increased to USD 708 billion in 2020, as reported by the National Science Foundation. Europe holds the second-largest region for market growth, primarily driven by the increasing consumer awareness of regenerative medicine.

Adipose Derived Stem Cell Market- Competitive Landscape:

The competitive landscape of the market for adipose-derived stem cells (ADSC) is shaped by the growing awareness of the therapeutic benefits of ADSCs in different medical fields. Businesses aim to set themselves apart by creating unique products and technologies for the isolation, expansion, and application of ADSCs in both research and clinical settings. They are also looking to broaden their reach in the ADSC market by venturing into new regions, forming partnerships with distributors, and focusing on emerging areas like regenerative aesthetics and veterinary medicine. Strategies for market expansion may involve obtaining regulatory approvals, launching market access initiatives, and forming strategic partnerships with influential figures in the healthcare industry.

Recent Developments:

In October 2023, as per Takeda's announcement, the Phase 3 ADMIRE-CD II research, which evaluated the safety and effectiveness of Alofisel(R) (darvadstrocel) in treating complex Crohn's Perianal Fistulas (CPF), failed to achieve its primary goal of combined remission at 24 weeks, according to topline results. Nothing new was found in terms of safety signals, and darvadstrocel's safety profile matched that of earlier research.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL Adipose Derived Stem Cell MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AlloCure

Antria

Celgene Corporation

Cellleris

Corestem

Cytori Therapeutics

Intrexon

Mesoblast

Pluristem Therapeutics

Tissue Genesis

BioRestorative Therapies

Celltex Therapeutics Corporation

iXCells Biotechnologies

Cyagen

Lonza

Others

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Autologous Stem Cells
  • Allogeneic Stem Cells

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cell line
  • Culture media
  • Media
  • Sera
  • Reagents

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Obesity
  • Wounds and Injuries
  • Musculoskeletal Diseases
  • Cardiovascular Diseases
  • Central Nervous System Diseases
  • Metabolic Diseases
  • Gastro-intestinal Diseases
  • Others

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Cell banks & tissue banks
  • Research laboratories and Academic institutes
  • Hospitals and Trauma centers
  • Other

GLOBAL ADIPOSE DERIVED STEM CELL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Adipose Derived Stem CellMarket Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Adipose Derived Stem CellMarket Snippet by Type
    • 2.1.2.Adipose Derived Stem CellMarket Snippet by Product Type
    • 2.1.3.Adipose Derived Stem CellMarket Snippet by Disease
    • 2.1.4.Adipose Derived Stem CellMarket Snippet by End-User
    • 2.1.5.Adipose Derived Stem CellMarket Snippet by Country
    • 2.1.6.Adipose Derived Stem CellMarket Snippet by Region
  • 2.2.Competitive Insights

3.Adipose Derived Stem CellKey Market Trends

  • 3.1.Adipose Derived Stem CellMarket Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Adipose Derived Stem CellMarket Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Adipose Derived Stem CellMarket Opportunities
  • 3.4.Adipose Derived Stem CellMarket Future Trends

4.Adipose Derived Stem CellIndustry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Adipose Derived Stem CellMarket: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Adipose Derived Stem CellMarket Landscape

  • 6.1.Adipose Derived Stem CellMarket Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Adipose Derived Stem CellMarket - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Autologous Stem Cells
    • 7.1.3.Allogeneic Stem Cells

8.Adipose Derived Stem CellMarket - By Product Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 8.1.2.Cell line
    • 8.1.3.Culture media
    • 8.1.4.Media
    • 8.1.5.Sera
    • 8.1.6.Reagents

9.Adipose Derived Stem CellMarket - By Disease

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 9.1.2.Cancer
    • 9.1.3.Obesity
    • 9.1.4.Wounds and Injuries
    • 9.1.5.Musculoskeletal Diseases
    • 9.1.6.Cardiovascular Diseases
    • 9.1.7.Central Nervous System Diseases
    • 9.1.8.Metabolic Diseases
    • 9.1.9.Gastro-intestinal Diseases
    • 9.1.10.Others

10.Adipose Derived Stem CellMarket - By End-User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2.Cell banks & tissue banks
    • 10.1.3.Research laboratories and Academic institutes
    • 10.1.4.Hospitals and Trauma centers
    • 10.1.5.Other

11.Adipose Derived Stem CellMarket- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Adipose Derived Stem CellKey Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Adipose Derived Stem CellKey Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Adipose Derived Stem CellKey Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Adipose Derived Stem CellKey Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Adipose Derived Stem CellKey Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Adipose Derived Stem CellIndustry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.AlloCure
    • 12.2.2.Antria
    • 12.2.3.Celgene Corporation
    • 12.2.4.Cellleris
    • 12.2.5.Corestem
    • 12.2.6.Cytori Therapeutics
    • 12.2.7.Intrexon
    • 12.2.8.Mesoblast
    • 12.2.9.Pluristem Therapeutics
    • 12.2.10.Tissue Genesis
    • 12.2.11.BioRestorative Therapies
    • 12.2.12.Celltex Therapeutics Corporation
    • 12.2.13.iXCells Biotechnologies
    • 12.2.14.Cyagen
    • 12.2.15.Lonza
    • 12.2.16.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us